The Motley Fool

PARA BIO FPO (ASX: PAR) Share Price and News

 Chart and Price Data

20mins delayed

Price
Bid/Ask /
Volume
Avg Daily Volume
Day Movement
Day High/Low /
52 Week Range -
Year Return (Capital)
As at
Please Wait...

PARA BIO FPO (ASX: PAR) Latest News

bull and bear figurines facing off over stockmarket graph

Opthea share price lifts on clinical trial update: Is it a spec buy?

Opthea Ltd (ASX: OPT) is developing clinical treatments for eye diseases. More »


ASX shares higher

Why Ausdrill, Link, Paradigm, & Village Roadshow shares raced higher today

The Ausdrill Limited (ASX:ASL) share price and the Village Roadshow Ltd (ASX:VRL) share price are two of four racing higher on Thursday. Here's why... More »


Here’s why the Opthea share price is up 130% today

Opthea Ltd (ASX: OPT) has released positive Phase II results for its OPT-302 + Lucentis (ranibizumab) combination therapy. More »


Healthcare technology shares

Why Telix Pharmaceuticals shares are up 80% over the past year

Telix Pharmaceuticals is an oncology researcher with a renal cancer treatment at the Phase III stage. More »


Businessman paying Australian money

Biotech speccy Paradigm is being tipped for the big time

Paradigm (ASX: PAR) has $78 million cash on hand and a goal to commercialise osteoarthritis drugs. More »


bull vs bear

Why the Next Science share price has more than tripled in 2019

Next Science (ASX: NXS) and Paradigm (ASX: PAR) are two widely fancied speccy biotechs. More »


Paradigm Biopharmaceuticals share price higher on Ross River virus trial results

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price has stormed higher this morning after announcing the results of a Ross River virus trial... More »


production of drugs in the lab

Paradigm Biopharmaceuticals share price higher on iPPS update

The Paradigm Biopharmaceuticals Ltd (ASX:PAR) share price climbed 3% on Tuesday after it released an iPPS update... More »


business share price

Will the Paradigm share price climb higher on promising ASX update?

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares could climb higher in early trade after a promising corporate update to the ASX this morning by the... More »


ASX shares to buy in May

Top ASX stock picks for May

Costa Group Holdings Ltd (ASX: CGC), Bellamy’s Australia Limited (ASX: BAL) and Macquarie Group Ltd (ASX: MQG) are among the Foolish writers' top ASX... More »


Large man falling off end of plank

Why Kogan, Northern Star, Paradigm, & Wagners shares tumbled lower today

The Kogan.com Ltd (ASX:KGN) share price and the Northern Star Resources Ltd (ASX:NST) share price are two of four tumbling notably lower on Wednesday.... More »


healthcare shares

Where does the Paradigm Biopharmaceuticals share price go from here?

Paradigm Biopharmaceuticals Ltd (ASX: PAR): buy, hold, sell? More »


share price higher

Why this ASX300 healthcare share price is up 414% in the last year

Paradigm Biopharmaceuticals Ltd (ASX: PAR) shares remain in a trading halt after announcing a capital raise to support the next phase of its osteoarthritis... More »


biotech shares

Over 610% higher in 12 months: The Paradigm share price still has plenty of growth ahead

The Paradigm Biopharmaceuticals Ltd (ASX: PAR) share price has zoomed 610% higher in 12 months to near its all-time high. Here is why I... More »